DXCM vs QTRX · P/E 63, rev $2.50B vs rev $69.3M
DexCom Inc (DXCM) versus Quanterix Corp (QTRX) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Quanterix Corp (QTRX) is a medical devices company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported QTRX revenue for 2026-06-30 was $69.3M. Net income was -$66.5M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. QTRX currently screens at market cap $274.8M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. QTRX currently screens at market cap $274.8M.
Not investment advice. Open the DXCM and QTRX stock pages for the full models.
Not investment advice.